Aspen Sinks to Four-Month Low as Volumes Surge After Glaxo Sells

  • Glaxo sold 6.2% stake in South African drugmaker at discount
  • About 4 million shares traded, or 3.1 times 3-month daily avg

Aspen Pharmacare Holdings Ltd. shares slumped to the lowest in more than four months and trading volumes surged after the U.K.’s GlaxoSmithKline Plc said it has disposed of the final portion of its stake in Africa’s largest generic drugmaker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.